Additional information
| Active substance | Gliclazide |
|---|---|
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Blood glucose monitoring, hemoglobin A1c |
| Also known as | Glyclazide |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | No significant impact on blood pressure |
| Trade name | Diamicron, among others |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | 1-(3-azabicyclo[3.3.0]oct-3-yl)-3-(p-tolylsulfonyl)urea |
| Formula | C15H21N3O3S |
| Substance class | Sulfonylurea |
| Main action | Hypoglycemic agent |
| Half-life | 10-12 hours |
| Dosage (medical) | Typically 40-120 mg per day, depending on patient response and formulation (immediate or extended release) |
| Dosage (sports) | Not applicable |
| Effects | Lowers blood glucose levels by stimulating insulin release from pancreatic beta cells |
| Side effects | Hypoglycemia, gastrointestinal disturbances (e.g., nausea, indigestion), dizziness, headache |
| Use in sports | Not typically used in sports |
| Manufacturer | Servier |
Prograf 5mg Astellas Pharma
Cialis 20 mg 4 Tabletten
DELETE - Micardis 80 mg Boehringer Ingelheim
Tavanic 500 mg Sanofi
Fostimon (Merional) 150 IU HMG IBSA
Champix Starter Pack Pfizer
AVELOX 400 Bayer
Fostimon (Merional) 75 (HMG) IBSA
Seretide Disckus (Advair) 500 mcg Glaxosmithkline 

Reviews
There are no reviews yet.